Results from the world’s first study on the use of portable MRI equipment during pediatric ECMO therapy were published April 4 in Critical Care.

OXOS Medical has ballooned its fundraising total to $45M, with Parkway Venture and Intel Capital leading the way, leaders announced.

The research fund aims to track the health of Americans for decades, with the intent of housing the long-term health information of 70% to 90% of the population.

The FDA-approved tool works by reprioritizing CTPA exams to the top of a radiologist’s work list when the scan is positive for PE.

Such behaviors may lead to delays in cancer diagnosis and treatment and adverse outcomes, experts wrote Tuesday in Radiology. 

ChatGPT isn’t capable of unilaterally guiding care for patients with cirrhosis or the liver cancer it tends to spawn, hepatocellular carcinoma (HCC). However, the large-language AI tool can competently assist clinicians.  

 Although rare, SIRVA made its way into headlines following the widespread rollout of COVID vaccines. This prompted a renewed push among the medical community to better define the side effect.

A popular marketer of handheld ultrasound devices has won FDA approval for an AI-enabled B-line quantification tool for use with patients suspected of having compromised lung function.